Yasushi Ichikawa

Yokohama, 2360004, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 237 publications

Clinical Outcomes of Peptide Receptor Radionuclide Therapy in Japanese Patients with Metastatic Rectal Neuroendocrine Tumors.

Clinical Outcomes of Peptide Receptor Radionuclide Therapy in Japanese Patients with Metastatic Rectal Neuroendocrine Tumors.

Journal: Cancers
Published: March 22, 2026

Long-term efficacy and safety of peptide receptor radionuclide therapy in Japanese patients with unresectable neuroendocrine tumor: extension of the Japanese phase I and phase I/II study.

Long-term efficacy and safety of peptide receptor radionuclide therapy in Japanese patients with unresectable neuroendocrine tumor: extension of the Japanese phase I and phase I/II study.

Journal: Annals of nuclear medicine
Published: December 20, 2025

Outcomes in patients with cancer following opioid initiation in Japan: an exploratory study.

Outcomes in patients with cancer following opioid initiation in Japan: an exploratory study.

Journal: BMC research notes
Published: September 24, 2025

Treatment of initially unresectable local advanced pancreatic adenocarcinoma with FOLFIRINOX: A prospective study YCOG1403 (C-FLAP study).

Treatment of initially unresectable local advanced pancreatic adenocarcinoma with FOLFIRINOX: A prospective study YCOG1403 (C-FLAP study).

Journal: Scientific reports
Published: March 24, 2025

Diagnostic Value of Contrast-Enhanced Dual-Energy Computed Tomography in the Pancreatic Parenchymal and Delayed Phases for Pancreatic Cancer.

Diagnostic Value of Contrast-Enhanced Dual-Energy Computed Tomography in the Pancreatic Parenchymal and Delayed Phases for Pancreatic Cancer.

Journal: Tomography (Ann Arbor, Mich.)
Published: August 23, 2024

Potential neuroendocrine differentiation in poorly differentiated colorectal adenocarcinoma: A hidden trait?

Potential neuroendocrine differentiation in poorly differentiated colorectal adenocarcinoma: A hidden trait?

Journal: Molecular and clinical oncology
Published: August 01, 2024

Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 cases.

Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 cases.

Journal: Journal of gastroenterology
Published: June 18, 2024

First-line Chemotherapy in Combination With Oral Recombinant Methioninase and a Low-methionine Diet for a Stage IV Inoperable Pancreatic-Cancer Patient Resulted in 40% Tumor Reduction and an 86% CA19-9 Biomarker Decrease.

First-line Chemotherapy in Combination With Oral Recombinant Methioninase and a Low-methionine Diet for a Stage IV Inoperable Pancreatic-Cancer Patient Resulted in 40% Tumor Reduction and an 86% CA19-9 Biomarker Decrease.

Journal: Anticancer research
Published: June 09, 2024

Primary Small Bowel Adenocarcinoma with Metastatic Ovarian Tumor in a Pregnant Woman.

Primary Small Bowel Adenocarcinoma with Metastatic Ovarian Tumor in a Pregnant Woman.

Journal: Case reports in oncology
Published: June 04, 2024

A Handheld Ultrasound Device Can Predict Constipation with Rectal Fecal Retention in a Palliative Care Setting.

A Handheld Ultrasound Device Can Predict Constipation with Rectal Fecal Retention in a Palliative Care Setting.

Journal: Diagnostics (Basel, Switzerland)
Published: May 27, 2024

[11C]Methionine PET vs. [18F]Fluorodeoxyglucose PET Whole-body Imaging to Determine the Extent of Methionine-addiction Compared to Glucose-addiction of Primary and Metastatic Cancer of the Trunk in Patients.

[11C]Methionine PET vs. [18F]Fluorodeoxyglucose PET Whole-body Imaging to Determine the Extent of Methionine-addiction Compared to Glucose-addiction of Primary and Metastatic Cancer of the Trunk in Patients.

Journal: Anticancer research
Published: April 26, 2024

Naldemedine and Magnesium Oxide as First-Line Medications for Opioid-Induced Constipation: A Comparative Database Study in Japanese Patients With Cancer Pain.

Naldemedine and Magnesium Oxide as First-Line Medications for Opioid-Induced Constipation: A Comparative Database Study in Japanese Patients With Cancer Pain.

Journal: Cureus
Published: March 05, 2024
Showing 1-12 of 237

Last Updated: 09/26/2026